Latest News for: bla
Edit
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for ...
Nasdaq Globe Newswire 23 Feb 2026
Edit
Deja Vu of Kargil? Why did Pakistan Army disown its soldiers in BLA captivity? Leaving ...
DNA India 21 Feb 2026
Edit
Chilling video: US ally’s troops captured by rebels, beg for rescue as BLA shows Pakistani soldiers
Hindustan Times 21 Feb 2026
The Balochistan Liberation Army (BLA) has released a disturbing video allegedly showing captured Pakistani soldiers pleading for help, ...
Edit
BLA unleashes video of captured Pakistani soldiers pleading for mercy as deadline looms
India TV 21 Feb 2026
The Balochistan Liberation Army (BLA), a banned separatist militant group, has escalated tensions in Pakistan's restive Balochistan province by releasing ...
Edit
'Why Have You Abandoned Us': BLA Releases Video Of Pakistani Soldiers Pleading For Help
News18 20 Feb 2026
According to the BLA’s claims, the soldiers were seized during what the group refers to as “Operation Herof 2.0”, a continuation of its insurgent campaign in Balochistan ....
Edit
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable ...
Business Wire 20 Feb 2026
Edit
NARCL places ₹285 crore anchor bid for BLA Power debt
The Times of India 20 Feb 2026
The National Asset Reconstruction Company Ltd has taken the ...
Edit
‘How can army ignore us?’: BLA releases video of captured Pakistan soldiers pleading for help
The Times of India 20 Feb 2026
The Baloch Liberation Army (BLA) reportedly released a video purportedly showing Pakistani ... The individuals, identified by the BLA as detained servicemen, are heard appealing to Pakistani authorities.
Edit
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) (Savara Inc)
Public Technologies 20 Feb 2026
Edit
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
Pharmiweb 20 Feb 2026
"We are proud to be the first to submit a BLA for an abatacept biosimilar which marks a significant milestone in our mission to increase patient access to critical, high-quality biologic therapies," said Milan Kalawadia, CEO, North America, at Dr.
Edit
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase accepted by the FDA
Pharmiweb 19 Feb 2026
HNSA), today announced that its Biologics License Application (BLA) for imlifidase has been accepted by the U.S ... The BLA submission for imlifidase is supported by the previously communicated highly statistically significant outcome of the pivotal U.S.
Edit
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase accepted by the FDA (Hansa Biopharma AB)
Public Technologies 18 Feb 2026
Edit
Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA (Hansa Biopharma AB)
Public Technologies 18 Feb 2026
2026-02-18 19.53.00 CET Hansa Biopharma AB - Inside information Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA ... The BLA submission for imlifidase is supported ...
Edit
Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA
PR Newswire 18 Feb 2026
HNSA), today announced that its Biologics License Application (BLA) for imlifidase has been accepted by the U.S ... The BLA submission for imlifidase is supported by the previously communicated highly statistically significant outcome of the pivotal U.S.
- 1
- 2
- Next page »